Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

617
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
617
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

3.9K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.9K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

2.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

10.4K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
10.4K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

4.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Open-Window Mapping Strategy for Wolff-Parkinson-White Syndrome in a Patient With Dextrocardia With Situs Inversus.

Pacing and clinical electrophysiology : PACE·2026
Same author

Alcohol consumption and risk of atrial fibrillation: a pairwise and network meta-analysis.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Ventricular Premature Complexes (TREAT-PVC): A Randomized Clinical Trial.

JACC. Clinical electrophysiology·2026
Same author

The Effect of Heparinization Practices on the Incidence of Deep Vein Thrombosis in Pediatric Ablations.

JACC. Clinical electrophysiology·2026
Same author

His-LBB Twig: The Origin for Premature Ventricular Complexes With Morphology Almost Identical to Sinus Rhythm.

JACC. Clinical electrophysiology·2025
Same author

Utility of short-term heart rate variability metrics in heart failure with reduced ejection fraction.

Heart rhythm O2·2025
Same journal

Conduction Guided Intervention: A First-in-Human Study of CTA-Guided Targeting of Proximal Conduction System Structures.

Heart rhythm·2026
Same journal

Circadian Pattern of Ventricular Fibrillation-Terminating Shocks among Patients with Diagnosed and Treated Congenital Long QT Syndrome.

Heart rhythm·2026
Same journal

High Rates of Permanent Pacemaker Implantation After Left-Sided Cardiac Surgery in Adults with Congenital Heart Disease.

Heart rhythm·2026
Same journal

Conduction system pacing versus biventricular pacing for cardiac resynchronization therapy: frequentist and bayesian meta-analysis of randomized controlled trial and propensity matched studies.

Heart rhythm·2026
Same journal

Take a Chance? Stroke Risk Management After Atrial Fibrillation Ablation.

Heart rhythm·2026
Same journal

Prominent T-wave induced by Valsalva maneuver associated with a RYR2 loss-of-function variant.

Heart rhythm·2026
See all related articles

Related Experiment Video

Updated: Apr 1, 2026

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

3.0K

Neuromodulation for cardiac arrhythmia.

Yuemei Hou1, Qina Zhou2, Sunny S Po3

  • 1Department of Cardiovascular Diseases, The 6th People's Hospital (Southern), Shanghai Jiaotong University, Shanghai, China.

Heart Rhythm
|October 7, 2015
PubMed
Summary
This summary is machine-generated.

The autonomic nervous system influences heart rhythm disorders. Neuromodulation therapies, by balancing nervous system activity, offer a promising new strategy for treating arrhythmias.

Keywords:
ArrhythmiaAtrial fibrillationAutonomic denervationAutonomic nervous systemNeuromodulationVentricular fibrillation

More Related Videos

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
06:40

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Published on: May 22, 2018

11.4K
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.9K

Related Experiment Videos

Last Updated: Apr 1, 2026

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

3.0K
Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
06:40

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Published on: May 22, 2018

11.4K
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.9K

Area of Science:

  • Cardiology
  • Neuroscience
  • Autonomic Nervous System Research

Background:

  • The autonomic nervous system significantly impacts the development and persistence of cardiac arrhythmias.
  • Imbalances in sympathetic and parasympathetic tone are implicated in arrhythmogenesis.

Purpose of the Study:

  • To explore neuromodulation as an emerging therapeutic strategy for treating arrhythmias.
  • To review various neuromodulation techniques targeting the autonomic nervous system for arrhythmia management.

Main Methods:

  • Review of emerging therapeutic approaches for arrhythmia treatment.
  • Focus on neuromodulation techniques aimed at modulating autonomic tone.

Main Results:

  • Neuromodulation strategies aim to enhance parasympathetic activity and reduce sympathetic drive.
  • Several techniques are identified, including vagal nerve stimulation, baroreceptor activation, and sympathetic denervation procedures.

Conclusions:

  • Neuromodulation represents a promising frontier in the non-pharmacological treatment of arrhythmias.
  • Targeting the autonomic nervous system offers diverse therapeutic avenues for managing complex heart rhythm disorders.